HEADER HYDROLASE 15-MAY-06 2H0J TITLE CRYSTAL STRUCTURE OF PUCM IN THE PRESENCE OF 5,6-DIAMINOURACIL COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSTHYRETIN-LIKE PROTEIN PUCM; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS SUBTILIS; SOURCE 3 ORGANISM_TAXID: 1423; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS BETA SANDWITCH, COMPLEX WITH DIAMINOURACIL, HIU, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.RHEE REVDAT 5 23-OCT-24 2H0J 1 REMARK SEQADV LINK REVDAT 4 18-OCT-17 2H0J 1 REMARK REVDAT 3 24-FEB-09 2H0J 1 VERSN REVDAT 2 11-JUL-06 2H0J 1 JRNL REVDAT 1 27-JUN-06 2H0J 0 JRNL AUTH D.-K.JUNG,Y.LEE,S.G.PARK,B.C.PARK,G.-H.KIM,S.RHEE JRNL TITL STRUCTURAL AND FUNCTIONAL ANALYSIS OF PUCM, A HYDROLASE IN JRNL TITL 2 THE UREIDE PATHWAY AND A MEMBER OF THE TRANSTHYRETIN-RELATED JRNL TITL 3 PROTEIN FAMILY. JRNL REF PROC.NATL.ACAD.SCI.USA V. 103 9790 2006 JRNL REFN ISSN 0027-8424 JRNL PMID 16782815 JRNL DOI 10.1073/PNAS.0600523103 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 991.00 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.0 REMARK 3 NUMBER OF REFLECTIONS : 7765 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.400 REMARK 3 FREE R VALUE TEST SET COUNT : 774 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1760 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 56 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.61100 REMARK 3 B22 (A**2) : -3.61100 REMARK 3 B33 (A**2) : 7.22200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.698 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.070 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.440 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.672 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 20.28 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DAU.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2H0J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-MAY-06. REMARK 100 THE DEPOSITION ID IS D_1000037777. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97144 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER PROTEUM 300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9261 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.10700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.54600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M AMMONIUM ACETATE, 0.5M NACL, 0.5M REMARK 280 AMMONIUM SULFATE, PH 4.2, VAPOR DIFFUSION, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 42 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z+1/2 REMARK 290 4555 Y,-X,Z+1/2 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z REMARK 290 7555 Y,X,-Z+1/2 REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 72.56350 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 72.56350 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 72.56350 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 72.56350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAIN A AND B FORMS INDEPENDENTLY A HOMOTETRAMER BY A REMARK 300 CRYSTALLOGRAPHIC SYMMETRY-RELATED MOLECULES REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 145.91200 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 1.000000 0.000000 -72.95600 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 72.95600 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 72.56350 REMARK 350 BIOMT1 4 0.000000 -1.000000 0.000000 72.95600 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 72.95600 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 72.56350 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 72.95600 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 145.12700 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 72.95600 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 145.12700 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 317 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 302 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 SER A 2 REMARK 465 GLU A 3 REMARK 465 PRO A 4 REMARK 465 GLU A 5 REMARK 465 SER A 6 REMARK 465 LEU A 7 REMARK 465 MSE A 80 REMARK 465 ASN A 81 REMARK 465 MSE B 1 REMARK 465 SER B 2 REMARK 465 GLU B 3 REMARK 465 PRO B 4 REMARK 465 GLU B 5 REMARK 465 SER B 6 REMARK 465 LEU B 7 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 14 132.44 177.70 REMARK 500 LEU A 18 2.25 -67.68 REMARK 500 ILE A 38 137.58 -35.66 REMARK 500 PRO A 53 154.94 -42.04 REMARK 500 SER A 62 138.75 -39.82 REMARK 500 GLN A 85 68.31 -159.10 REMARK 500 THR A 89 -77.63 -103.30 REMARK 500 HIS B 14 119.11 -165.63 REMARK 500 LEU B 34 131.10 -39.64 REMARK 500 GLU B 36 169.56 -49.55 REMARK 500 ILE B 38 119.50 -39.31 REMARK 500 ARG B 49 -169.36 -126.35 REMARK 500 PRO B 53 151.72 -42.36 REMARK 500 ALA B 82 -2.21 56.26 REMARK 500 GLN B 85 69.69 -117.41 REMARK 500 PHE B 87 -31.09 -38.79 REMARK 500 THR B 89 -81.89 -142.28 REMARK 500 ALA B 98 -77.08 -71.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE URN A 122 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2H0E RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE ABSENCE OF INHIBITOR REMARK 900 RELATED ID: 2H0F RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN THE PRESENCE OF INHIBITOR, 8-AZAXANTHINE DBREF 2H0J A 1 121 UNP O32142 PUCM_BACSU 1 121 DBREF 2H0J B 1 121 UNP O32142 PUCM_BACSU 1 121 SEQADV 2H0J MSE A 1 UNP O32142 MET 1 MODIFIED RESIDUE SEQADV 2H0J MSE A 8 UNP O32142 MET 8 MODIFIED RESIDUE SEQADV 2H0J MSE A 39 UNP O32142 MET 39 MODIFIED RESIDUE SEQADV 2H0J MSE A 61 UNP O32142 MET 61 MODIFIED RESIDUE SEQADV 2H0J MSE A 67 UNP O32142 MET 67 MODIFIED RESIDUE SEQADV 2H0J MSE A 80 UNP O32142 MET 80 MODIFIED RESIDUE SEQADV 2H0J MSE B 1 UNP O32142 MET 1 MODIFIED RESIDUE SEQADV 2H0J MSE B 8 UNP O32142 MET 8 MODIFIED RESIDUE SEQADV 2H0J MSE B 39 UNP O32142 MET 39 MODIFIED RESIDUE SEQADV 2H0J MSE B 61 UNP O32142 MET 61 MODIFIED RESIDUE SEQADV 2H0J MSE B 67 UNP O32142 MET 67 MODIFIED RESIDUE SEQADV 2H0J MSE B 80 UNP O32142 MET 80 MODIFIED RESIDUE SEQRES 1 A 121 MSE SER GLU PRO GLU SER LEU MSE GLY LYS LEU THR THR SEQRES 2 A 121 HIS ILE LEU ASP LEU THR CYS GLY LYS PRO ALA ALA ASN SEQRES 3 A 121 VAL LYS ILE GLY LEU LYS ARG LEU GLY GLU SER ILE MSE SEQRES 4 A 121 LYS GLU VAL TYR THR ASN ASN ASP GLY ARG VAL ASP VAL SEQRES 5 A 121 PRO LEU LEU ALA GLY GLU GLU LEU MSE SER GLY GLU TYR SEQRES 6 A 121 VAL MSE GLU PHE HIS ALA GLY ASP TYR PHE ALA SER LYS SEQRES 7 A 121 ASN MSE ASN ALA ALA ASP GLN PRO PHE LEU THR ILE VAL SEQRES 8 A 121 THR VAL ARG PHE GLN LEU ALA ASP PRO ASP ALA HIS TYR SEQRES 9 A 121 HIS ILE PRO LEU LEU LEU SER PRO PHE GLY TYR GLN VAL SEQRES 10 A 121 TYR ARG GLY SER SEQRES 1 B 121 MSE SER GLU PRO GLU SER LEU MSE GLY LYS LEU THR THR SEQRES 2 B 121 HIS ILE LEU ASP LEU THR CYS GLY LYS PRO ALA ALA ASN SEQRES 3 B 121 VAL LYS ILE GLY LEU LYS ARG LEU GLY GLU SER ILE MSE SEQRES 4 B 121 LYS GLU VAL TYR THR ASN ASN ASP GLY ARG VAL ASP VAL SEQRES 5 B 121 PRO LEU LEU ALA GLY GLU GLU LEU MSE SER GLY GLU TYR SEQRES 6 B 121 VAL MSE GLU PHE HIS ALA GLY ASP TYR PHE ALA SER LYS SEQRES 7 B 121 ASN MSE ASN ALA ALA ASP GLN PRO PHE LEU THR ILE VAL SEQRES 8 B 121 THR VAL ARG PHE GLN LEU ALA ASP PRO ASP ALA HIS TYR SEQRES 9 B 121 HIS ILE PRO LEU LEU LEU SER PRO PHE GLY TYR GLN VAL SEQRES 10 B 121 TYR ARG GLY SER MODRES 2H0J MSE A 8 MET SELENOMETHIONINE MODRES 2H0J MSE A 39 MET SELENOMETHIONINE MODRES 2H0J MSE A 61 MET SELENOMETHIONINE MODRES 2H0J MSE A 67 MET SELENOMETHIONINE MODRES 2H0J MSE B 8 MET SELENOMETHIONINE MODRES 2H0J MSE B 39 MET SELENOMETHIONINE MODRES 2H0J MSE B 61 MET SELENOMETHIONINE MODRES 2H0J MSE B 67 MET SELENOMETHIONINE MODRES 2H0J MSE B 80 MET SELENOMETHIONINE HET MSE A 8 8 HET MSE A 39 8 HET MSE A 61 8 HET MSE A 67 8 HET MSE B 8 8 HET MSE B 39 8 HET MSE B 61 8 HET MSE B 67 8 HET MSE B 80 8 HET URN A 122 10 HETNAM MSE SELENOMETHIONINE HETNAM URN 5,6-DIAMINOPYRIMIDINE-2,4(1H,3H)-DIONE HETSYN URN 5,6-DIAMINOURACIL FORMUL 1 MSE 9(C5 H11 N O2 SE) FORMUL 3 URN C4 H6 N4 O2 FORMUL 4 HOH *56(H2 O) HELIX 1 1 GLU A 58 LEU A 60 5 3 HELIX 2 2 HIS A 70 SER A 77 1 8 HELIX 3 3 HIS B 70 LYS B 78 1 9 SHEET 1 A 3 LYS A 22 PRO A 23 0 SHEET 2 A 3 LYS A 10 ASP A 17 -1 N ASP A 17 O LYS A 22 SHEET 3 A 3 LEU A 55 ALA A 56 -1 O LEU A 55 N LEU A 11 SHEET 1 B 4 LYS A 22 PRO A 23 0 SHEET 2 B 4 LYS A 10 ASP A 17 -1 N ASP A 17 O LYS A 22 SHEET 3 B 4 HIS A 103 SER A 111 1 O LEU A 108 N HIS A 14 SHEET 4 B 4 GLY A 114 VAL A 117 -1 O GLN A 116 N LEU A 109 SHEET 1 C 4 LYS A 40 TYR A 43 0 SHEET 2 C 4 LYS A 28 ARG A 33 -1 N ILE A 29 O VAL A 42 SHEET 3 C 4 GLY A 63 PHE A 69 -1 O GLU A 68 N GLY A 30 SHEET 4 C 4 VAL A 91 LEU A 97 -1 O PHE A 95 N TYR A 65 SHEET 1 D 3 LYS B 22 PRO B 23 0 SHEET 2 D 3 LYS B 10 ASP B 17 -1 N ASP B 17 O LYS B 22 SHEET 3 D 3 LEU B 55 ALA B 56 -1 O LEU B 55 N LEU B 11 SHEET 1 E 4 LYS B 22 PRO B 23 0 SHEET 2 E 4 LYS B 10 ASP B 17 -1 N ASP B 17 O LYS B 22 SHEET 3 E 4 HIS B 103 SER B 111 1 O TYR B 104 N THR B 12 SHEET 4 E 4 GLY B 114 VAL B 117 -1 O GLN B 116 N LEU B 109 SHEET 1 F 4 LYS B 40 TYR B 43 0 SHEET 2 F 4 LYS B 28 ARG B 33 -1 N ILE B 29 O VAL B 42 SHEET 3 F 4 GLY B 63 PHE B 69 -1 O GLU B 68 N GLY B 30 SHEET 4 F 4 VAL B 91 LEU B 97 -1 O PHE B 95 N TYR B 65 LINK C MSE A 8 N GLY A 9 1555 1555 1.33 LINK C ILE A 38 N MSE A 39 1555 1555 1.33 LINK C MSE A 39 N LYS A 40 1555 1555 1.33 LINK C LEU A 60 N MSE A 61 1555 1555 1.33 LINK C MSE A 61 N SER A 62 1555 1555 1.33 LINK C VAL A 66 N MSE A 67 1555 1555 1.33 LINK C MSE A 67 N GLU A 68 1555 1555 1.32 LINK C MSE B 8 N GLY B 9 1555 1555 1.33 LINK C ILE B 38 N MSE B 39 1555 1555 1.33 LINK C MSE B 39 N LYS B 40 1555 1555 1.33 LINK C LEU B 60 N MSE B 61 1555 1555 1.33 LINK C MSE B 61 N SER B 62 1555 1555 1.33 LINK C VAL B 66 N MSE B 67 1555 1555 1.33 LINK C MSE B 67 N GLU B 68 1555 1555 1.33 LINK C ASN B 79 N MSE B 80 1555 1555 1.33 LINK C MSE B 80 N ASN B 81 1555 1555 1.33 SITE 1 AC1 5 HIS A 14 ARG A 49 HIS A 105 PRO A 107 SITE 2 AC1 5 TYR A 118 CRYST1 72.956 72.956 145.127 90.00 90.00 90.00 P 42 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013710 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013710 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006890 0.00000 HETATM 1 N MSE A 8 -25.252 64.787 52.204 1.00 80.21 N HETATM 2 CA MSE A 8 -24.885 63.702 51.250 1.00 80.45 C HETATM 3 C MSE A 8 -23.762 64.145 50.313 1.00 77.00 C HETATM 4 O MSE A 8 -23.644 63.666 49.183 1.00 76.18 O HETATM 5 CB MSE A 8 -26.118 63.270 50.443 1.00 86.81 C HETATM 6 CG MSE A 8 -26.664 64.311 49.467 1.00 94.05 C HETATM 7 SE MSE A 8 -26.037 64.064 47.640 1.00106.89 SE HETATM 8 CE MSE A 8 -27.491 62.992 46.925 1.00100.69 C